序号 |
标题 |
次数 |
作者 |
发布时间 |
73711 |
4-Ketobenzotriazine-CH2-S-(CH2)5-COOH,CAS号:221334-33-4 |
150 |
h |
2024-12-24 |
73712 |
Fmoc-PEG3-C2-NHS ester,CAS号:1352827-47-4 |
73 |
h |
2024-12-24 |
73713 |
DOTA-TATE,CAS:177943-89-4, DOTA-3-酪氨酰基-奥曲肽 |
128 |
zyl |
2024-12-24 |
73714 |
Stearic acid-PEG-CH2CO2H, MW 2000 |
78 |
h |
2024-12-24 |
73715 |
FmocNH-PEG2-CH2CO2-NHS ester的结构特点,1194666-63-1 |
138 |
wyh |
2024-12-24 |
73716 |
Thalidomide-NH-CH2-COOH,CAS号:927670-97-1 |
107 |
h |
2024-12-24 |
73717 |
盐酸氨溴索脂质体,Ambroxol Hydrochloride Liposome |
83 |
axc |
2024-12-24 |
73718 |
Stearic acid-PEG-CH2CO2H (MW 3400) |
79 |
h |
2024-12-24 |
73719 |
CEP1347-VHL-02 |
107 |
h |
2024-12-24 |
73720 |
DOTA-GA(tBu)4 cas306776-79-4 大环配体化合物 |
178 |
zyl |
2024-12-24 |
73721 |
Z-NH-(CH2)8-NH2·HCl ; N1-叔苄氧羰基-1,8-二氨基辛烷盐酸盐 |
109 |
wyh |
2024-12-24 |
73722 |
Stearic acid-PEG-CH2CO2H (MW 5000) |
144 |
h |
2024-12-24 |
73723 |
Curcumin Liposome,姜黄素脂质体 |
355 |
axc |
2024-12-24 |
73724 |
Stearic acid-PEG-CH2CO2H (MW 1000) |
86 |
h |
2024-12-24 |
73725 |
SJF-1528 hemihydrate |
93 |
h |
2024-12-24 |
73726 |
Azido-PEG1-CH2CO2H的应用领域,79598-48-4 |
136 |
wyh |
2024-12-24 |
73727 |
Ac-Pro-Leu-Val-Glu(OMe)-CH2F |
93 |
h |
2024-12-24 |
73728 |
乳酸左氧氟沙星脂质体,Levofloxacin Lactate Liposome |
84 |
axc |
2024-12-24 |
73729 |
Azido-PEG1-CH2CO2-NHS的化学结构,2144777-77-3 |
80 |
wyh |
2024-12-24 |
73730 |
Tos-PEG1-O-CH2COOH具体解释和潜在应用 |
103 |
h |
2024-12-24 |
73731 |
Fmoc-NH-PEG2-CH2COOH,CAS号:166108-71-0,[2-[2-(Fmoc-氨基)乙氧基]乙氧基]乙酸 |
79 |
h |
2024-12-24 |
73732 |
Val-cit-PAB-OH,抗体- 药物偶联物,159857-79-1 |
84 |
hyy |
2024-12-24 |
73733 |
THP-PEG4-Pyrrolidine(N-Me)-CH2OH,CAS号:2378261-81-3 |
80 |
h |
2024-12-24 |
73734 |
Azido-PEG1-CH2CO2-NHS的应用领域,cas:2144777-77-3 |
105 |
wyh |
2024-12-24 |
73735 |
THP-PEG4-Pyrrolidine(N-Boc)-CH2OH,CAS号:2378261-80-2 |
80 |
h |
2024-12-24 |
73736 |
PEG3-O-CH2COOH,CAS号:51951-05-4,三聚乙二醇-乙酸 |
89 |
h |
2024-12-24 |
73737 |
Fmoc-NH-PEG3-amide-CH2OCH2COOH,CAS号:489427-26-1 |
73 |
h |
2024-12-24 |
73738 |
Levofloxacin Lactate Liposome,乳酸左氧氟沙星脂质体 |
98 |
axc |
2024-12-24 |
73739 |
PROTAC STAT3 degrader-3 |
87 |
h |
2024-12-24 |
73740 |
三氧杂十一碳二酸,Azido-PEG5-CH2CO2-PFP |
103 |
wyh |
2024-12-24 |
73741 |
Me-triacetyl-β-D-glucopyranuronate-Ph-CH2OH-Fmoc,CAS号:894096-02-7 |
78 |
h |
2024-12-24 |
73742 |
Boc-NH-PEG1-Ph-O-CH2COOH,CAS号:2361117-22-6 |
135 |
h |
2024-12-24 |
73743 |
Sodium Ferulate Liposome,阿魏酸钠脂质体 |
87 |
axc |
2024-12-24 |
73744 |
DSPE-PEG-CH2COOH, MW 2000 |
81 |
h |
2024-12-24 |
73745 |
DSPE-PEG-CH2COOH, MW 5000 |
81 |
h |
2024-12-24 |
73746 |
6-Maleimidohexanoic acid N-hydroxysuccinimide ester,55750-63-5,ADC试剂 |
126 |
hyy |
2024-12-24 |
73747 |
Bis-PEG1-C-PEG1-CH2COOH,CAS号:2358775-67-2 |
109 |
h |
2024-12-24 |
73748 |
Azido-PEG5-CH2CO2-PFP的性质与应用,2144777-92-2 |
110 |
wyh |
2024-12-24 |
73749 |
Ceftiofur Hydrochloride Liposome,盐酸头孢噻呋脂质体 |
102 |
axc |
2024-12-24 |
73750 |
Fmoc-N-PEG-CH2COOH (MW 3400) |
181 |
h |
2024-12-24 |
73751 |
N3-PEG3-CH2COOH具体解释和潜在应用 |
65 |
h |
2024-12-24 |
73752 |
Flumazenil Liposome,氟马西尼脂质体 |
86 |
axc |
2024-12-24 |
73753 |
m-PEG6-O-CH2COOH,CAS号:75427-75-7 |
111 |
h |
2024-12-24 |
73754 |
Azido-PEG5-Boc,叠氮-聚乙二醇5-羧基叔丁酯 |
124 |
wyh |
2024-12-24 |
73755 |
HO-PEG-CH2COOH (MW 10000)具体解释和潜在应用 |
126 |
h |
2024-12-24 |